SummitTX Capital, L.P.

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 2052310 FORT WORTH, TX

Position in AMLX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,089,312

+$933,873 QoQ

Shares Held

227,690

+0.3% QoQ

Ownership

0.204%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#58

of 207 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SummitTX Capital, L.P. holds $15,646,022 across 5 Drug Manufacturers - Specialty & Generic names. AMLX ranks #2 (26.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	134,194	$7,031,765
2	AMLX	Amylyx Pharmaceuticals, Inc. This page	227,690	$4,089,312
3	PRGO	PERRIGO Co plc	231,555	$2,405,856
4	SUPN	Supernus Pharmaceuticals, Inc.	27,151	$1,262,793
5	PBH	Prestige Consumer Healthcare Inc.	18,115	$856,296

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,089,312	227,690	+0.3%	Shares	Sole	2026-08-14
2026-03-31	$3,155,439	227,010	+3.9%	Shares	Sole	2026-05-15
2025-12-31	$2,638,259	218,399	+30.0%	Shares	Sole	2026-02-17
2025-09-30	$2,283,120	168,000	—	Shares	Defined	2025-11-14
No filing history on record for this holder in this stock.